Adicet Bio vs Tharimmune
Adicet Bio vs Tharimmune, compared side by side on 16 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adicet Bio is on 48/100 and Tharimmune on 53/100.
Where each one leads
Adicet Bio
- domain rating: 38/100 against 26/100
Tharimmune
- our overall score: 53/100 against 48/100
- agent readiness: 31/100 against 23/100
- funding raised: $540M against $389M
At a glance
| Measure | Adicet Bio | Tharimmune |
|---|---|---|
| What it is | Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases. | Biotechnology company developing novel immunotherapies for cancer. |
| Category | Biotech, HealthTech, Oncology, Autoimmune Diseases | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2014 | 2017 |
| Headquarters | Boston, United States | Cambridge, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adicet Bio | Tharimmune |
|---|---|---|
| Employees | Not published | 13 |
| Total funding | $389M | $540M |
| Latest round | Registered Direct Offering | Not published |
| LinkedIn followers | Not published | 1,718 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adicet Bio | Tharimmune |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 48/100 | 53/100 |
| Traction | 40/100 | 51/100 |
| Team | 50/100 | 70/100 |
| Community | 8/100 | 15/100 |
| Search visibility | 19/100 | 22/100 |
| Quality | 58/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (23/100) | F (31/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 26/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adicet Bio | Tharimmune |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| CMS | Not detected | Webflow |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
Adicet Bio vs Tharimmune: common questions
Which is better, Adicet Bio or Tharimmune?
On our 0-100 score Tharimmune rates higher (53/100 against 48/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 16 data points above: read the rows that match what you are buying for.
How do Adicet Bio and Tharimmune compare on the numbers?
Adicet Bio leads on domain rating (38/100 against 26/100). Tharimmune leads on our overall score (53/100 against 48/100), agent readiness (31/100 against 23/100), funding raised ($540M against $389M).
Read the full Adicet Bio review and pricing or the Tharimmune review and pricing. You can also browse other Adicet Bio alternatives we track.